Insider Financial Recent Winners: (NASDAQ:ETRM) (OTCMKTS:OWCP) (OTCMKTS:ICNB)

It's been an exciting time for us and our subscribers at Insider Financial these past few months. There's been no shortage of small cap runners for penny stock investors trading across the NASDAQ and OTC Markets. We offer our readers an overview on each company while providing our subscribers with more in-depth coverage and special situations in a timely fashion. It's our small cap newsletter where the real value lies. That's why we're highlighting three small caps that our subscribers were able to achieve maximum gains.EnteroMedics Inc (NASDAQ:ETRM)ETRM is a name that we started covering on October 6. You can read our full coverage here. We stressed that the most important factor was ETRM picking up insurance coverage for vBloc. We said that we were watching closely for any sign of an insurance carrier backing down and covering the procedure.Early last month, we got some positive news that MedStar Health in Maryland and Roper St. Francis in South Carolina became the twelfth and thirteenth centers to qualify as vBloc institutes in the US. The news sparked a short covering rally and the stock went from $2 to as high as $30 on January 10. That is a gain of over 1200% in less than two weeks.We then said that a pullback was likely and that the gains came more on the back of short covering rather than the insurance coverage we were looking for. Our subscribers were able to get out before this pullback and move to the sidelines as we said the situation was uncertain. As a result, ETRM turned into a big winner for our subscribers as profits got booked.OWC Pharmaceutical Research Corp (OTCMKTS:OWCP)OWCP is another one that we started covering back in October. You can read our full coverage here. We were bullish on this one from the beginning. Prior to our coverage, OWCP was trading as low as $.0030 back in September. Last month, OWCP hit highs of $.95 a share, delivering gains of over 31,000%!! Even now at $.66 a share, early investors are up over 21,000% on their money. For those that got in just this year, OWCP started the year around $.16 a share and is up 300% so far in 2017.For those not familiar with the company, OWCP is a pharmaceutical cannabis company based in Israel. It is working on the development and commercialization of a number of different cannabis-based assets, targeting a range of pharmaceutical indications, in both Israel and internationally. The primary asset, and the one that we think will drive the most near-term value, is a psoriasis cream. Beyond psoriasis, OWCP is also pushing a multiple myeloma candidate through early stage trials, with the goal of getting the asset in question into clinical studies before the end of this year. OWCP is also working on a sublingual tablet designed to offer physicians a measurable and quantifiable method of dosing patients with cannabis related treatments.Going forward, we expect operational updates to be the primary driver. The psoriasis cream is basically in its final round of efficacy testing before it hits the shelves. The company expects to have it commercially available in the US and Israel by the end of the first quarter and sales push starting second quarter. These are updates we will keep our subscribers in the loop on.Iconic Brands Inc (OTCMKTS:ICNB)We alerted our readers on December 23 that things were heating up for ICNB. You can read our full coverage here. ICNB was a name that we had on our radar for all of 2016 and we were just waiting to see who the celebrity spokesperson would be for its Bellissima Prosecco Italian sparkling wine. Once we found out it was Christie Brinkley, we knew that the bull run was just getting started. On December 23, ICNB was trading at just $.0030 a share. Now it's trading around $.0217 a share, for gains of over 600%.There’s quite a bit happening at Iconic and leads us to believe that the momentum is set to continue. The company just announced that it’s closing in on 1000 US retailers for the Bellissima brand, and are in the process of facilitating a Letter of Credit with the manufacturer to streamline the financial process for production; this will allow the manufacturer to procure on an as needed basis all the raw goods inclusive of bottles, corks, decorative, and cages.Going forward, we expect sales figures to be the primary driver of the stock price. We said it last month and we'll say it again: part of the speculative frenzy surrounding ICNB is that the company could be a takeover target for a major drinks player. One name that has been bandied about is Diageo plc (NYSE:DEO). While we don't like to comment on speculation, the fit makes sense.These are just three examples of the research coverage we provide at Insider Financial. As you can see from our coverage, we are not Monday morning Quarterbacks. Our coverage is verified and proven. To stay on top of the latest small caps and to catch moving tickers like ETRM, OWCP, and ICNB - sign up below!Disclosure: We have no position in ETRM, OWCP, or ICNB and have not been compensated for this article.